High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages

  Onuma, Hiroshi ^a,h   Tohyama, Mikiko ^a   Imagawa, Akihisa ^b   Hanafusa, Toshiaki ^c   Kobayashi, Tetsuro ^d   Kano, Yoko ^e   Ohashi, Jun ^f   Hashimoto, Koji ^a   Osawa, Haruhiko ^a,h   Makino, Hideichi ^g  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TSUKUBA   (Japan)

^g Shiraishi Hospital Diabetes Center   (Japan)

^h EHIME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; DAPSONE; GLUCOSE; HEMOGLOBIN A1C; HLA ANTIGEN CLASS 1; HLA B62 ANTIGEN; HLA DR ANTIGEN; MEXILETINE; MINOCYCLINE; PHENYTOIN; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; ZONISAMIDE;

ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DRESS SYNDROME; FEMALE; FULMINANT TYPE 1 DIABETES; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN HERPESVIRUS 6; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MALE; MOLECULAR PATHOLOGY; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE; VIRUS REACTIVATION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; DATA COLLECTION; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DRUG HYPERSENSITIVITY; FEMALE; GENE FREQUENCY; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; SYNDROME; YOUNG ADULT;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6;

EID: 84870755128     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2054     Document Type: Article

References (19)

1. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y 2000 A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 342:301-307 (Pubitemid 30075242)
2. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H 2003 Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26:2345-2352 (Pubitemid 36993324)
3. Imagawa A, Hanafusa T 2011 Fulminant type 1 diabetes-an important subtype in East Asia. Diabetes Metab Res Rev 27:959-964
4. Tohyama M, Hashimoto K 2011 New aspects of drug-induced hypersensitivity syndrome. J Dermatol 38:222-228
5. Hashimoto H, Makino H, Kanatsuka A, Fujiwara T, Sakurada M, Iwaoka H, Taira M, Osawa K, Yanmaguchi T, Yoshida S 1987 A case of insulin-dependent diabetes mellitus with Coxsackie B3 virus infection following diaminodiphenyl sulfone (DDS) syndrome. J Jpn Diabetes Soc 30:761-765
6. Sekine N, Motokura T, Oki T, Umeda Y, Sasaki N, Hayashi M, Sato H, Fujita T, Kaneko T, Asano Y, Kikuchi K 2001 Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285:1153-1154 (Pubitemid 32198479)
7. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K 2007 The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156:1083-1084 (Pubitemid 46642847)
8. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH 2007 Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157:934-940 (Pubitemid 47583515)
9. Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, Kawasaki E, Tanaka S, Shimada A, Osawa H, Kobayashi T, Hanafusa T, Tokunaga K, Makino H 2009 Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 52:2513-2521
10. Nakamura K, Aihara M, Mitani N, Tanaka Y, Ikegawa Z 2005 Clinical analysis of 94 Japanese patients with drug-induced hypersensitivity syndrome. Jpn J Dermatol 115:1779-1790
11. Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z 13 September 2011 A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Pharmacogenomics J 10.1038/tpj.2011.41
12. Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto K, Kamatani N, Nakamura Y 2011 Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 20:1034-1041
13. Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B 2012 Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA 109:9959-9964
14. Liu Z, Cort L, Eberwine R, Herrmann T, Leif JH, Greiner DL, Yahalom B, Blankenhorn EP, Mordes JP 2012 Prevention of type 1 diabetes in the rat with an allele-specific anti-T-cell receptor antibody: Vβ13 as a therapeutic target and biomarker. Diabetes 61:1160-1168
15. Seino Y, Yamauchi M, Hirai C, Okumura A, Kondo K, Yamamoto M, Okazaki Y 2004 A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome. Diabet Med 21:1156-1157 (Pubitemid 39389233)
16. Kano Y, Hiraharas K, Sakuma K, Shiohara T 2006 Several herpes-viruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 155:301-306 (Pubitemid 44050562)
17. Kobayashi T, Nishida Y, Tanaka S, Aida K 2011 Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab Res Rev 27:965-970
18. Murao S, Makino H, Kaino Y, Konoue E, Ohashi J, Kida K, Fujii Y, Shimizu I, Kawasaki E, Fujiyama M, Kondo S, Tanaka K, Tarumi Y, Seto I, Kato K, Ohno K, Kusunoki Y, Ebisui O, Takada Y, Tanabe K, Takemoto K, Onuma H, Nishimiya T, Osawa H 2004 Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 53:2684-2690 (Pubitemid 39299279)
19. Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, Cowen EW 2009 Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 145:63-66